HELE vs MGPI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
HELE exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 2/9, indicating weak fundamental health. While valuation metrics like Price/Book (0.45) and Forward P/E (4.99) suggest the stock is undervalued, these are likely 'value traps' given the catastrophic 5-year price decline of 92.3% and a deeply negative ROE of -63.90%. The combination of shrinking revenue, negative profit margins, and a bearish technical trend suggests a company in a structural decline rather than a temporary dip.
MGPI presents a classic 'value trap' profile: fundamentally healthy but operationally declining. While the Piotroski F-Score of 7/9 indicates strong financial health and the balance sheet is robust (Debt/Equity 0.37), the company is facing a severe growth crisis with revenue down 23.5% and EPS down 59.9% YoY. The stock is deeply undervalued on a Price-to-Book (0.57) and Price-to-Sales (0.77) basis, but this is offset by bearish insider activity and a nearly unsustainable dividend payout ratio of 96%.
Compare Another Pair
Related Comparisons
HELE vs MGPI: Head-to-Head Comparison
This page compares Helen of Troy Limited (HELE) and MGP Ingredients, Inc. (MGPI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.